Показано 0 из 0
Дата |
---|
11.08.2022 |
10.08.2022 |
09.08.2022 |
08.08.2022 |
03.08.2022 |
02.08.2022 |
28.07.2022 |
27.07.2022 |
26.07.2022 |
25.07.2022 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
5.087
|
5.087
|
5.29
|
5.165
|
|
|
1 137.00
|
|
|
|
5.14
|
5.14
|
5.14
|
5.14
|
|
|
|
|
|
|
5.14
|
5.14
|
5.14
|
5.14
|
|
|
5.00
|
|
|
|
5.165
|
5.165
|
5.165
|
5.165
|
|
|
|
|
|
|
4.5845
|
4.5845
|
4.595
|
4.595
|
|
|
4 590.00
|
|
|
|
4.674
|
4.674
|
4.674
|
4.674
|
|
|
|
|
|
|
5.16
|
5.16
|
5.16
|
5.16
|
|
|
|
|
|
|
5.10
|
5.10
|
5.10
|
5.10
|
|
|
|
|
|
|
4.9525
|
4.9525
|
4.9525
|
4.9525
|
|
|
|
|
|
|
4.8675
|
4.8675
|
4.8675
|
4.8675
|
|
|
|
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.